Michael Stolz

Michael Stolz has extensive experience in intellectual property, currently serving as Director of Intellectual Property at CureVac since April 2016. Prior to this role, Michael held positions as Associate Director and Senior Manager of Intellectual Property at the same company. From January 2007 to January 2016, Michael worked as a European Patent Attorney at Kanzlei Fitzner PartGmbB. Earlier in his career, Michael was involved in research at Forschungszentrum Jülich, where a doctorate in biotechnology was obtained at RWTH Aachen University from 2003 to 2006.